Quality compounder in technical downtrend warrants 50% allocation with disciplined scaling, not full deployment.
Scale-in Overweight with disciplined entry below current levels. The fundamental thesis (Hess integration, $12B deleveraging, PEG 0.89, 3.5% yield) warrants exposure, but the technical breakdown (MACD -1.67, RSI 45 no capitulation, 47.3M share distribution day) makes chasing the current tape a Sept 17-style execution error.
| Position | Action |
|---|---|
| Tier 1 entry zone ($195-197) | Scale in at lower end of 50 SMA / lower Bollinger confluence zone |
| Tier 2 entry ($193-196) | Trigger on reclaim of 50 SMA from below with positive MACD histogram turn |
| Position sizing | 50% of standard allocation, NOT 70% |
The technical pullback from $217.77 to $202.41 represents a buyable dip within a structural uptrend—11.4% above the 200 SMA—driven by the Hess acquisition transforming earnings power, a $7B+ Venezuela commitment, and LNG positioning that institutions are accumulating into rather than shorting.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 208.55 | bearish |
| close_50_sma | 198.85 | neutral |
| close_200_sma | 181.75 | bullish |
| macd | 2.65 | bearish |
| macds | 4.32 | bearish |
| rsi | 45.06 | bearish |
| boll_ub | 219.27 | neutral |
| boll_lb | 197.70 | bearish |
| atr | 4.54 | neutral |
| vwma | 210.69 | bearish |
Support: 197.7 · 198.85 · 181.75 | Resistance: 208.55 · 210.69 · 217.77 · 219.27
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $193-196 on confirmation
Then: Trigger on reclaim of 50 SMA from below with positive MACD histogram turn
↩ rebuts: “Bear's 'Q2 was an outlier' thesis”
EV: +7.6% to Target 1 ($217.77 from $202.41); +13.6%+ to Target 2 ($230+)
CVX is breaking down on every short-term timeframe that matters, the Q2 earnings spike is a dangerous one-quarter outlier, Venezuela exposure is political risk masquerading as growth, and the risk-reward is asymmetric to the downside.
EV: -$190 → $185 (downside targets) · concedes: Q2 2026 EPS was genuinely strong; CVX may be a great business at $160; Short-term weakness could be followed by brief rallies toward $208-210
→ vs conservative: Waiting for 200 SMA at 181.75 or 184 creates 5-6 points of yield-on-cash drag and a HIGHER forward P/E multiple when entering, as earnings will have rolled forward; this is timing the wrong variable
→ vs conservative: Citing absence of retail chatter as fragility is misread — institutional accumulation at discount prices without retail froth is how durable bull legs start
→ vs conservative: Waiting for MACD positive, RSI bullish divergence, and reclaim of 10 EMA with volume means CVX would already be at 210-215 when all confirmations stack up
→ vs neutral: The 192.50 stop already blunts the technical breakdown risk the neutral analyst is citing; no scenario presented where trade loses more than 3%
→ vs neutral: The conservative analyst's Q2 base effect concern misses that Q2 was an INFLECTION not a SPIKE — Hess contribution compounds, not fades
Bearish short-term bias within a constructive long-term framework. The stock has undergone a sharp, high-volume distribution event, breaking below the 10 EMA, Bollinger middle band, and VWMA. Momentum (MACD below signal with histogram at −1.67) and breadth (RSI 45.06, not oversold) confirm weakness without reaching oversold extremes. The 200 SMA at 181.75 remains the secular invalidation level. A close below 197.70 opens a move to ~190 then ~185; bullish invalidation requires reclaiming 213 on volume with RSI > 55. Recommendation: HOLD for existing holders; new capital should wait for a confirmed bottom above 197.70 or a structural re-entry in the 180s.
Market Capitalization
$397.05B
P/E (TTM)
19.48
Forward P/E
14.92
PEG Ratio
0.89
Price/Book
2.09
EPS (TTM)
$10.39
Forward EPS
$13.56
Dividend Yield
3.50%
FCF (TTM)
$21.93B
Revenue (TTM)
$209.38B
Gross Profit
$92.69B
EBITDA
$50.66B
Net Income
$20.59B
Operating Margin
21.87%
Profit Margin
9.83%
ROE
12.23%
ROA
5.86%
Total Assets
$330.14B
Net PPE
$215.94B
Goodwill
$4.57B
Total Equity
$189.88B
Long-Term Debt
$36.67B
Total Debt
$37.08B
Net Debt
$28.55B
Cash & Equivalents
$8.53B
Working Capital
$9.90B
Current Ratio
1.25
Q2 2026 Net Income
$12.07B
Q2 2026 Diluted EPS
$6.11
Q2 2026 Operating Cash Flow
$22.63B
Q2 2026 Free Cash Flow
$18.10B
Q2 2026 Capital Expenditure
-$4.54B
FCF Coverage of Div+Buyback
~2.8x
52-Week Range
$146.49 – $217.78
50-Day MA
$199.31
200-Day MA
$184.17
Beta
0.491
Buyback Yield (TTM)
~2.8%
Strengths
Concerns
Chevron screens as a quality integrated energy major with an attractive forward valuation (forward P/E 14.92, PEG 0.89) supported by the Q2 2026 inflection point where a single quarter generated $12.07B in net income (59% of TTM). The Hess acquisition closed Q3 2025, adding Guyana Stabroek exposure with equity-method earnings surging to $2.13B in Q2 2026. The balance sheet is deleveraging rapidly (net debt fell from $40.1B to $28.55B in one quarter) while maintaining a 3.5% dividend with 2.8x FCF coverage. However, trading near the 52-week high limits margin of safety, and the heavy Q2 earnings concentration creates vulnerability to commodity price reversals. HOLD with positive bias is recommended; accumulation favored on pullbacks toward the 200-day MA (~$184).
Macro: HAWKISH — The Fed has just hiked rates for the first time since 2023 (Polymarket: 96% probability of zero cuts in 2026, $8.48M market). Recession risk is low (8% by end-2026, down 7pp on the week). Iran invasion odds at 14% ($68.4M market) but trending down 2pp/week — de-escalation = oil price pressure. Soft landing/no-landing consensus is supportive for energy demand. The hawkish, real-asset-friendly regime is the most supportive macro for integrated majors since 2022. China demand is a medium-term bear flag as it re-normalizes Iranian crude imports.